Your browser doesn't support javascript.
loading
The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense.
Horton, Julie L; Davidson, Michael T; Kurishima, Clara; Vega, Rick B; Powers, Jeffery C; Matsuura, Timothy R; Petucci, Christopher; Lewandowski, E Douglas; Crawford, Peter A; Muoio, Deborah M; Recchia, Fabio A; Kelly, Daniel P.
Afiliación
  • Horton JL; Center for Metabolic Origins of Disease, Sanford Burnham Prebys Medical Discovery Institute at Lake Nona (SBP-LN), Orlando, Florida, USA.
  • Davidson MT; Departments of Medicine and Pharmacology, and Cancer Biology, and Duke Molecular Physiology Institute, Duke University, Durham, North Carolina, USA.
  • Kurishima C; Department of Physiology, Cardiovascular Research Center, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.
  • Vega RB; Center for Metabolic Origins of Disease, Sanford Burnham Prebys Medical Discovery Institute at Lake Nona (SBP-LN), Orlando, Florida, USA.
  • Powers JC; Department of Physiology, Cardiovascular Research Center, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.
  • Matsuura TR; Cardiovascular Institute and Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Petucci C; Center for Metabolic Origins of Disease, Sanford Burnham Prebys Medical Discovery Institute at Lake Nona (SBP-LN), Orlando, Florida, USA.
  • Lewandowski ED; Cardiovascular Institute and Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Crawford PA; Center for Metabolic Origins of Disease, Sanford Burnham Prebys Medical Discovery Institute at Lake Nona (SBP-LN), Orlando, Florida, USA.
  • Muoio DM; Davis Heart and Lung Research Institute and Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, Ohio, USA.
  • Recchia FA; Center for Metabolic Origins of Disease, Sanford Burnham Prebys Medical Discovery Institute at Lake Nona (SBP-LN), Orlando, Florida, USA.
  • Kelly DP; Departments of Medicine and Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, Minnesota, USA.
JCI Insight ; 4(4)2019 02 21.
Article en En | MEDLINE | ID: mdl-30668551
ABSTRACT
Evidence has emerged that the failing heart increases utilization of ketone bodies. We sought to determine whether this fuel shift is adaptive. Mice rendered incapable of oxidizing the ketone body 3-hydroxybutyrate (3OHB) in the heart exhibited worsened heart failure in response to fasting or a pressure overload/ischemic insult compared with WT controls. Increased delivery of 3OHB ameliorated pathologic cardiac remodeling and dysfunction in mice and in a canine pacing model of progressive heart failure. 3OHB was shown to enhance bioenergetic thermodynamics of isolated mitochondria in the context of limiting levels of fatty acids. These results indicate that the heart utilizes 3OHB as a metabolic stress defense and suggest that strategies aimed at increasing ketone delivery to the heart could prove useful in the treatment of heart failure.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Ácido 3-Hidroxibutírico / Metabolismo Energético / Insuficiencia Cardíaca / Ventrículos Cardíacos / Miocardio Tipo de estudio: Etiology_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: JCI Insight Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Ácido 3-Hidroxibutírico / Metabolismo Energético / Insuficiencia Cardíaca / Ventrículos Cardíacos / Miocardio Tipo de estudio: Etiology_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: JCI Insight Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos